Company: DKI
Filing Date: 2025-08-11
Form Type: 424B4
Source: 0001641172-25-022921
Chunk: 0

Company: DarkIris Inc.
Filing Date: 2025-08-11
Form: 424B4
Chunk 0
---
PROSPECTUS

Filed pursuant to Rule 424(b)(4)

Registration No. 333-288004

<div align='center'>DARKIRIS INC.

黑瞳科技

1,500,000Class A Ordinary Shares</div>

This is an initial public offering of the Class A ordinary shares, par value US$0.0001 per share (the “ Class A Ordinary Shares”) of DarkIris Inc. 黑瞳科技 (“ DarkIris”). This is the initial public offering of our Class A Ordinary Shares. Prior to this offering, there has been no public market for Class A Ordinary Shares. The initial public offering price of the Class A Ordinary Shares is $4 per share.

OurClass A Ordinary Shares have been approved for listing on the Nasdaq Capital Market, or Nasdaq, under the symbol “DKI” on or promptly after the date of this prospectus.

We are an “emerging growth company” as defined under the federal securities laws and are subject to reduced public company reporting requirements. See “Prospectus Summary — Implications of Our Being an “Emerging Growth Company” and “Risk Factors” on pages 4 and 12, respectively.

We have a dual-class
voting structure consisting of Class A Ordinary Shares and Class B Ordinary Shares. Based on our dual-class voting structure,
holders of Class A Ordinary Shares will be entitled to one (1) vote per share in respect of matters requiring the votes of
shareholders including the election of directors, amendment of memorandum and articles of association, and approval of major corporate
transactions, while holders of Class B Ordinary Shares will be entitled to twenty (20) votes per share. Due to the disparate voting
powers associated with our two classes of ordinary shares, Hong Zhifang, our Chief Executive Officer, director and Controlling Shareholder,
will beneficially own approximately 31.14% of our issued and outstanding share capital, and approximately 90.04% aggregate
voting power of our Company immediately following the completion of this offering, assuming that the underwriters do not exercise their
over-allotment option. The interests of our Controlling Shareholder may not coincide with your interests, and it may make decisions with
which you disagree, including decisions on important topics such as the composition of the board of directors, compensation, management
succession, and our business and financial strategy. To the extent that the interests of our Controlling Shareholder differ from your
interests, you